Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigen

Oncology Letters

Volumn 7, Issue 2, 2014, Pages 568-572

  Chen, Shaohua ^a   Dai, Yuqiao ^b   Zhang, Xuemei ^a   Jin, Daozhong ^c   Li, Xiaorong ^a   Zhang, Yi ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoembryonic antigen; Colorectal carcinoma; MiR 449a

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MICRORNA 449A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UPREGULATION;

EID: 84890340760     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1737     Document Type: Article

References (21)

1. Corté H, Manceau G, Blons H and Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis 44: 195-200, 2012.
2. Boyle P and Levin B (eds): Colorectal cancer. In: World Cancer Report 2008. IARC Press, Lyon, pp374-378, 2008.
3. Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in Human Cancer. Adv Exp Med Biol 774: 1-20, 2013.
4. Zhu W, Liu X, He J, Chen D, Hunag Y and Zhang YK: Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 11: 393, 2011.
5. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, HirataH, Giardina C and Dahiya R: miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28: 1714-1724, 2009.
6. Noonan EJ, Place RF, Basak S, Pookot D and Li LC: miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1: 349-358, 2010.
7. Jeon HS, Lee SY, Lee EJ, Yun SC, Cha EJ, Choi E, Na MJ, ParkJY, Kang J and Son JW: Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. Lung Cancer 76: 171-176, 2012.
8. Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F and Skawran B: Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 143: 811-820, 2012.
9. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B, Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 18;10: 29, 2011.
10. Zhang Q, He XJ, Ma LP, Li N, Yang J, Cheng YX and Cui H: Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues. Zhonghua Zhong Liu Za Zhi 33: 885-890, 2011 (In Chinese).
11. Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M and Yu Q: miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev 23: 2388-2393, 2009.
12. Chen H, Lin YW, Mao YQ, Wu J, Liu YF, Zheng XY and XieLP: MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett320: 40-47, 2012.
13. Lizé M, Pilarski S and Dobbelstein M: E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 17: 452-458, 2010.
14. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD and GudaK: The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47: 939-946, 2008.
15. Lardizábal MN, Nocito AL, Daniele SM, Ornella LA, PalatnikJF and Veggi LM: Reference genes for real-time PCR quantification of microRNAs and messenger RNAs in rat models of hepatotoxicity. PLoS One 7: e36323, 2012.
16. Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng Y and Bi F: miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett 585: 2998-3005, 2011.
17. Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, GleaveM, Gout PW and Wang Y: MicroRNAs associated with metastatic prostate cancer. PLoS One 6: e24950, 2011.
18. Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, JohnsonDN, Giangreco AA, Martens-Uzunova E, Bagasra O, Kajdacsy-BallaA and Nonn L: miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem 286: 44503-44511, 2011.
19. Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W, Liu J, Yu J and Chen J: miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 70: 6015-6025, 2010.
20. Boras Z, Kondza G, Sisljagić V, Busić Z, Gmajnić R and IstvanićT: Prognostic factors of local recurrence and survival after curative rectal cancer surgery: a single institution experience. Coll Antropol 36: 1355-1361, 2012.
21. Meimarakis G, Angele M, Conrad C, Schauer R, WeidenhagenR, Crispin A, Giessen C, Preissler G, Wiedemann M, JauchKW, etal: Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone. LangenbecksArchSurg 398: 265-276, 2013.